MIS12
gene geneOn this page
Also known as MGC2488hMIS12KNTC2APMTW1
Summary
MIS12 (MIS12 kinetochore complex component, HGNC:24967) is a protein-coding gene on chromosome 17p13.2, encoding Protein MIS12 homolog (Q9H081). Part of the MIS12 complex which is required for normal chromosome alignment and segregation and for kinetochore formation during mitosis. It is a common-essential gene (DepMap: required in 94.3% of cancer cell lines).
Involved in attachment of mitotic spindle microtubules to kinetochore and kinetochore assembly. Located in kinetochore and nucleus. Part of MIS12/MIND type complex.
Source: NCBI Gene 79003 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 26 total
- Cancer dependency (DepMap): dependent in 94.3% of screened cell lines (common-essential)
- MANE Select transcript:
NM_001258217
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:24967 |
| Approved symbol | MIS12 |
| Name | MIS12 kinetochore complex component |
| Location | 17p13.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC2488, hMIS12, KNTC2AP, MTW1 |
| Ensembl gene | ENSG00000167842 |
| Ensembl biotype | protein_coding |
| OMIM | 609178 |
| Entrez | 79003 |
Gene structure
Transcript identifiers
Ensembl transcripts: 27 — 26 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000381165, ENST00000573759, ENST00000574186, ENST00000576570, ENST00000576988, ENST00000611091, ENST00000891287, ENST00000891288, ENST00000891289, ENST00000891290, ENST00000891291, ENST00000891292, ENST00000891293, ENST00000891294, ENST00000891295, ENST00000891296, ENST00000891297, ENST00000916906, ENST00000916907, ENST00000916908, ENST00000916909, ENST00000960710, ENST00000960711, ENST00000960712, ENST00000960713, ENST00000960714, ENST00000960715
RefSeq mRNA: 5 — MANE Select: NM_001258217
NM_001258217, NM_001258218, NM_001258219, NM_001258220, NM_024039
CCDS: CCDS11074
Canonical transcript exons
ENST00000611091 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001117575 | 5488196 | 5488589 |
| ENSE00003727833 | 5488823 | 5490811 |
| ENSE00003746052 | 5486566 | 5486684 |
Expression profiles
Bgee: expression breadth ubiquitous, 279 present calls, max score 91.35.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 14.1610 / max 247.2464, expressed in 1770 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 159038 | 5.7127 | 1593 |
| 159037 | 3.5594 | 1509 |
| 159039 | 2.3604 | 1225 |
| 159040 | 1.6098 | 856 |
| 159036 | 0.9187 | 523 |
Top tissues by expression
288 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| corpus epididymis | UBERON:0004359 | 91.35 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 90.20 | gold quality |
| parietal pleura | UBERON:0002400 | 89.53 | gold quality |
| bronchial epithelial cell | CL:0002328 | 89.06 | gold quality |
| pleura | UBERON:0000977 | 88.50 | gold quality |
| visceral pleura | UBERON:0002401 | 88.40 | gold quality |
| tibia | UBERON:0000979 | 88.38 | gold quality |
| superficial temporal artery | UBERON:0001614 | 88.34 | gold quality |
| ventricular zone | UBERON:0003053 | 88.16 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 87.92 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 87.55 | gold quality |
| mucosa of paranasal sinus | UBERON:0005030 | 87.53 | gold quality |
| caput epididymis | UBERON:0004358 | 87.44 | gold quality |
| granulocyte | CL:0000094 | 87.19 | gold quality |
| vermiform appendix | UBERON:0001154 | 87.12 | gold quality |
| islet of Langerhans | UBERON:0000006 | 87.03 | gold quality |
| cauda epididymis | UBERON:0004360 | 87.00 | gold quality |
| secondary oocyte | CL:0000655 | 86.97 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 86.92 | gold quality |
| amniotic fluid | UBERON:0000173 | 86.91 | gold quality |
| ganglionic eminence | UBERON:0004023 | 86.77 | gold quality |
| body of pancreas | UBERON:0001150 | 86.35 | gold quality |
| lymph node | UBERON:0000029 | 86.28 | gold quality |
| spleen | UBERON:0002106 | 86.18 | gold quality |
| pancreas | UBERON:0001264 | 85.95 | gold quality |
| endometrium | UBERON:0001295 | 85.91 | gold quality |
| lower lobe of lung | UBERON:0008949 | 85.75 | gold quality |
| esophagus squamous epithelium | UBERON:0006920 | 85.68 | gold quality |
| rectum | UBERON:0001052 | 85.61 | gold quality |
| colonic mucosa | UBERON:0000317 | 85.58 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 3.93 |
| E-GEOD-110499 | no | 578.26 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
55 targeting MIS12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-574-5P | 100.00 | 66.01 | 989 |
| HSA-MIR-513A-5P | 100.00 | 69.77 | 2465 |
| HSA-MIR-30A-5P | 100.00 | 76.31 | 3233 |
| HSA-MIR-30B-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30C-5P | 100.00 | 76.29 | 3248 |
| HSA-MIR-30D-5P | 100.00 | 76.32 | 3233 |
| HSA-MIR-30E-5P | 100.00 | 76.32 | 3242 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-570-3P | 99.96 | 72.41 | 4910 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-381-3P | 99.93 | 71.87 | 2854 |
| HSA-MIR-300 | 99.92 | 71.76 | 2856 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-LET-7A-2-3P | 99.87 | 70.53 | 1921 |
| HSA-LET-7G-3P | 99.85 | 70.43 | 1929 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-370-5P | 99.78 | 66.81 | 706 |
| HSA-MIR-3156-3P | 99.76 | 66.72 | 939 |
| HSA-MIR-132-3P | 99.73 | 70.56 | 1424 |
| HSA-MIR-212-3P | 99.73 | 70.65 | 1424 |
| HSA-MIR-3714 | 99.71 | 70.74 | 2671 |
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-545-5P | 99.66 | 70.18 | 2308 |
| HSA-MIR-516A-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-516B-3P | 99.46 | 67.96 | 1378 |
| HSA-MIR-7162-5P | 99.46 | 68.08 | 1368 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 94.3% of screened cell lines, common-essential.
Literature-anchored findings (GeneRIF, showing 8)
- hMIS12 has a role in mitosis and localizes at kinetochores (PMID:12515822)
- These results indicate that a four-subunit Mis12 complex plays an essential role in chromosome segregation in vertebrates and contributes to mitotic kinetochore assembly. (PMID:16585270)
- These findings support a novel role for Hsp90-Sgt1 chaperones in ensuring the fidelity of Mis12 multiprotein complex assembly. (PMID:20404110)
- Direct binding of Cenp-C to the Mis12 complex joins the inner and outer kinetochore. (PMID:21353556)
- RWD-containing proteins interact with the Mis12 complex to shape KMN network topology, as revealed by structural analysis (PMID:24530301)
- Mechanisms of mitosis-specific assembly of the checkpoint platform Knl1/MIS12/NDC80 at human kinetochores. (PMID:25601404)
- Whereas CENP-C recruits a single MIS12:NDC80 complex, the authors show here that CENP-T binds one MIS12:NDC80 and two NDC80 complexes upon phosphorylation by the mitotic CDK1:Cyclin B complex at three distinct CENP-T sites. (PMID:28012276)
- METTL3 counteracts premature aging via m6A-dependent stabilization of MIS12 mRNA. (PMID:33035345)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | mis12 | ENSDARG00000026454 |
| mus_musculus | Mis12 | ENSMUSG00000040599 |
| rattus_norvegicus | Mis12 | ENSRNOG00000066036 |
Protein
Protein identifiers
Protein MIS12 homolog — Q9H081 (reviewed: Q9H081)
All UniProt accessions (3): Q9H081, I3L244, I3L4K6
UniProt curated annotations — full annotation on UniProt →
Function. Part of the MIS12 complex which is required for normal chromosome alignment and segregation and for kinetochore formation during mitosis. Essential for proper kinetochore microtubule attachments.
Subunit / interactions. Component of the MIS12 complex composed of MIS12, DSN1, NSL1 and PMF1. Also interacts with KNL1, CBX3, CBX5, NDC80 and ZWINT.
Subcellular location. Chromosome. Centromere. Kinetochore.
Similarity. Belongs to the mis12 family.
RefSeq proteins (5): NP_001245146, NP_001245147, NP_001245148, NP_001245149, NP_076944 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008685 | Centromere_Mis12 | Family |
Pfam: PF05859
UniProt features (10 total): helix 6, chain 1, coiled-coil region 1, sequence variant 1, strand 1
Structure
Experimental structures (PDB)
4 structures.
| PDB | Method | Resolution (Å) |
|---|---|---|
| 8PPR | ELECTRON MICROSCOPY | 3 |
| 5LSJ | X-RAY DIFFRACTION | 3.25 |
| 5LSK | X-RAY DIFFRACTION | 3.5 |
| 8Q5H | ELECTRON MICROSCOPY | 4.5 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q9H081-F1 | 88.12 | 0.53 |
Function
Pathways and Gene Ontology
Reactome pathways
18 pathways
| ID | Pathway |
|---|---|
| R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal |
| R-HSA-2467813 | Separation of Sister Chromatids |
| R-HSA-2500257 | Resolution of Sister Chromatid Cohesion |
| R-HSA-5663220 | RHO GTPases Activate Formins |
| R-HSA-68877 | Mitotic Prometaphase |
| R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation |
| R-HSA-141424 | Amplification of signal from the kinetochores |
| R-HSA-162582 | Signal Transduction |
| R-HSA-1640170 | Cell Cycle |
| R-HSA-194315 | Signaling by Rho GTPases |
| R-HSA-195258 | RHO GTPase Effectors |
| R-HSA-2555396 | Mitotic Metaphase and Anaphase |
| R-HSA-68882 | Mitotic Anaphase |
| R-HSA-68886 | M Phase |
| R-HSA-69278 | Cell Cycle, Mitotic |
| R-HSA-69618 | Mitotic Spindle Checkpoint |
| R-HSA-69620 | Cell Cycle Checkpoints |
| R-HSA-9716542 | Signaling by Rho GTPases, Miro GTPases and RHOBTB3 |
MSigDB gene sets: 147 (showing top):
GOBP_CHROMOSOME_ORGANIZATION, MYAATNNNNNNNGGC_UNKNOWN, GOBP_ATTACHMENT_OF_SPINDLE_MICROTUBULES_TO_KINETOCHORE, GOBP_CHROMOSOME_LOCALIZATION, GEORGES_CELL_CYCLE_MIR192_TARGETS, GGGTGGRR_PAX4_03, MARTINEZ_RB1_TARGETS_UP, GOBP_ORGANELLE_FISSION, GOBP_MITOTIC_NUCLEAR_DIVISION, GOBP_ORGANELLE_ASSEMBLY, MCBRYAN_PUBERTAL_BREAST_5_6WK_UP, GOBP_MITOTIC_CELL_CYCLE, FISCHER_DREAM_TARGETS, GOBP_ORGANELLE_LOCALIZATION, GOBP_KINETOCHORE_ORGANIZATION
GO Biological Process (7): mitotic sister chromatid segregation (GO:0000070), chromosome segregation (GO:0007059), attachment of spindle microtubules to kinetochore (GO:0008608), cell division (GO:0051301), attachment of mitotic spindle microtubules to kinetochore (GO:0051315), kinetochore assembly (GO:0051382), mitotic cell cycle (GO:0000278)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (8): MIS12/MIND type complex (GO:0000444), kinetochore (GO:0000776), spindle pole (GO:0000922), outer kinetochore (GO:0000940), nucleus (GO:0005634), cytosol (GO:0005829), chromosome, centromeric region (GO:0000775), chromosome (GO:0005694)
Reactome top-level categories
Rollup of top-13 pathways:
| Category | Pathways |
|---|---|
| Mitotic Prometaphase | 2 |
| M Phase | 2 |
| Cell Cycle | 2 |
| Amplification of signal from the kinetochores | 1 |
| Mitotic Anaphase | 1 |
| RHO GTPase Effectors | 1 |
| Mitotic Spindle Checkpoint | 1 |
| Signaling by Rho GTPases, Miro GTPases and RHOBTB3 | 1 |
| Signaling by Rho GTPases | 1 |
| Mitotic Metaphase and Anaphase | 1 |
| Cell Cycle, Mitotic | 1 |
| Cell Cycle Checkpoints | 1 |
| Signal Transduction | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| mitotic nuclear division | 2 |
| mitotic cell cycle process | 2 |
| cell cycle process | 2 |
| intracellular membraneless organelle | 2 |
| cellular anatomical structure | 2 |
| sister chromatid segregation | 1 |
| microtubule binding | 1 |
| metaphase chromosome alignment | 1 |
| cellular process | 1 |
| mitotic metaphase chromosome alignment | 1 |
| attachment of spindle microtubules to kinetochore | 1 |
| kinetochore organization | 1 |
| protein-containing complex assembly | 1 |
| membraneless organelle assembly | 1 |
| cell cycle | 1 |
| binding | 1 |
| outer kinetochore | 1 |
| condensed chromosome, centromeric region | 1 |
| supramolecular complex | 1 |
| spindle | 1 |
| kinetochore | 1 |
| protein-containing complex | 1 |
| intracellular membrane-bounded organelle | 1 |
| cytoplasm | 1 |
| chromosomal region | 1 |
Protein interactions and networks
STRING
740 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| MIS12 | DSN1 | Q9H410 | 984 |
| MIS12 | KNL1 | Q8NG31 | 973 |
| MIS12 | CENPC | Q03188 | 851 |
| MIS12 | NDC80 | O14777 | 836 |
| MIS12 | SPC24 | Q8NBT2 | 817 |
| MIS12 | CENPI | Q92674 | 802 |
| MIS12 | CENPH | Q9H3R5 | 769 |
| MIS12 | NUF2 | Q9BZD4 | 767 |
| MIS12 | ZWINT | O95229 | 731 |
| MIS12 | CENPT | Q96BT3 | 729 |
| MIS12 | CENPA | P49450 | 620 |
| MIS12 | CENPS | Q8N2Z9 | 577 |
| MIS12 | AURKB | Q96GD4 | 570 |
| MIS12 | CENPB | P07199 | 555 |
| MIS12 | BUB1 | O43683 | 514 |
IntAct
113 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MIS12 | PMF1 | psi-mi:“MI:0915”(physical association) | 0.950 |
| PMF1 | MIS12 | psi-mi:“MI:0915”(physical association) | 0.950 |
| PMF1 | MIS12 | psi-mi:“MI:2364”(proximity) | 0.950 |
| MIS12 | PMF1 | psi-mi:“MI:2364”(proximity) | 0.950 |
| NUF2 | NDC80 | psi-mi:“MI:0914”(association) | 0.950 |
| ZWINT | NDC80 | psi-mi:“MI:0914”(association) | 0.940 |
| SPC25 | NDC80 | psi-mi:“MI:0914”(association) | 0.940 |
| DSN1 | MIS12 | psi-mi:“MI:2364”(proximity) | 0.930 |
BioGRID (205): MIS12 (Two-hybrid), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), MIS12 (Affinity Capture-MS), PMF1 (Co-purification), MIS12 (Affinity Capture-MS), CDKN2A (Affinity Capture-MS), CENPC (Affinity Capture-MS), NDC80 (Affinity Capture-MS), ZWINT (Affinity Capture-MS)
ESM2 similar proteins: A4D1B5, A8MW99, A8Y5U1, O70173, O88480, Q12769, Q1LV50, Q1T769, Q1T7B7, Q1T7B8, Q28HU3, Q3MHH2, Q3TCV3, Q3U1D0, Q3ZAU7, Q402B2, Q5EA49, Q5PNP6, Q5R9W0, Q5RB52, Q5ZL79, Q63517, Q6DRL4, Q6IPU0, Q6P2C0, Q6TNU3, Q7TQ72, Q7Z2Z1, Q7Z4M0, Q8AYS7, Q8BJW5, Q8BKT8, Q8BMG1, Q8BQ33, Q8BR90, Q8BRM6, Q8K2A7, Q8NG48, Q91VB4, Q92674
Diamond homologs: Q1T769, Q5EA49, Q5R9W0, Q7TQ72, Q9CY25, Q9H081
SIGNOR signaling
1 interactions.
| A | Effect | B | Mechanism |
|---|---|---|---|
| MIS12 | “form complex” | “MIS12 complex” | binding |
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 56 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Amplification of signal from the kinetochores | 8 | 39.4× | 5e-10 |
| Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal | 13 | 37.9× | 1e-15 |
| Mitotic Spindle Checkpoint | 8 | 31.7× | 2e-09 |
| EML4 and NUDC in mitotic spindle formation | 13 | 30.2× | 1e-14 |
| Resolution of Sister Chromatid Cohesion | 13 | 28.1× | 2e-14 |
| RHO GTPases Activate Formins | 13 | 25.2× | 6e-14 |
| Mitotic Prometaphase | 13 | 22.5× | 2e-13 |
| Cell Cycle Checkpoints | 9 | 19.9× | 9e-09 |
GO biological processes:
| GO term | Partners | Fold | FDR |
|---|---|---|---|
| attachment of spindle microtubules to kinetochore | 8 | 162.8× | 1e-14 |
| mitotic spindle assembly checkpoint signaling | 7 | 85.5× | 1e-10 |
| chromosome segregation | 7 | 26.4× | 3e-07 |
| cell division | 13 | 13.1× | 6e-10 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
26 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 22 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
509 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 17:5488282:A:T | donor_gain | 1.0000 |
| 17:5488813:A:AG | acceptor_gain | 1.0000 |
| 17:5488814:C:G | acceptor_gain | 1.0000 |
| 17:5488815:A:AG | acceptor_gain | 1.0000 |
| 17:5488815:ATTT:A | acceptor_gain | 1.0000 |
| 17:5488816:T:G | acceptor_gain | 1.0000 |
| 17:5488818:TGCA:T | acceptor_loss | 1.0000 |
| 17:5488819:GCAG:G | acceptor_loss | 1.0000 |
| 17:5488820:CAG:C | acceptor_loss | 1.0000 |
| 17:5488821:A:AG | acceptor_gain | 1.0000 |
| 17:5488821:A:AT | acceptor_loss | 1.0000 |
| 17:5488821:AG:A | acceptor_gain | 1.0000 |
| 17:5488822:G:GT | acceptor_gain | 1.0000 |
| 17:5488822:GG:G | acceptor_gain | 1.0000 |
| 17:5488822:GGT:G | acceptor_gain | 1.0000 |
| 17:5488822:GGTT:G | acceptor_gain | 1.0000 |
| 17:5488822:GGTTT:G | acceptor_gain | 1.0000 |
| 17:5487100:G:GT | donor_gain | 0.9900 |
| 17:5488281:G:GT | donor_gain | 0.9900 |
| 17:5488302:GC:G | donor_gain | 0.9900 |
| 17:5488818:T:TA | acceptor_gain | 0.9900 |
| 17:5488265:GCC:G | donor_gain | 0.9800 |
| 17:5488274:GAA:G | donor_gain | 0.9800 |
| 17:5487088:GAGT:G | donor_gain | 0.9700 |
| 17:5487087:G:GT | donor_gain | 0.9600 |
| 17:5487101:A:T | donor_gain | 0.9600 |
| 17:5486682:CCGGT:C | donor_loss | 0.9500 |
| 17:5486683:CGGT:C | donor_loss | 0.9500 |
| 17:5486684:GGTA:G | donor_loss | 0.9500 |
| 17:5486685:G:GG | donor_gain | 0.9500 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000334647 (17:5487321 G>A,T), RS1000863037 (17:5487478 T>C), RS1000873701 (17:5487584 T>C), RS1000969450 (17:5486755 C>G), RS1001075134 (17:5486363 C>CA,CG,CT), RS1001858131 (17:5489326 C>G,T), RS1002241079 (17:5485758 G>A), RS1002312057 (17:5488867 C>T), RS1002739768 (17:5489585 A>G), RS1002890012 (17:5485401 G>A), RS1002908833 (17:5490544 A>G), RS1003934686 (17:5485433 T>G), RS1005092559 (17:5487014 A>G), RS1005150452 (17:5486920 A>C,G), RS1005412399 (17:5491040 T>C)
Disease associations
OMIM: gene MIM:609178 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST009303_2 | Abstraction and mental flexibility | 9.000000e-06 |
| GCST009391_1683 | Metabolite levels | 1.000000e-06 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0009332 | executive function measurement |
| EFO:0010343 | cholesteryl ester 18:0 measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
35 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Particulate Matter | increases abundance, decreases reaction, increases expression, decreases expression | 4 |
| Air Pollutants | increases abundance, increases expression, decreases expression | 2 |
| Vehicle Emissions | decreases reaction, increases expression, increases abundance | 2 |
| Tunicamycin | increases expression | 2 |
| Valproic Acid | decreases expression, affects cotreatment, increases expression | 2 |
| Zinc | affects cotreatment, increases expression, decreases expression | 2 |
| Cyclosporine | increases expression | 2 |
| 3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamide | decreases expression | 1 |
| dicrotophos | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| bisphenol A | affects cotreatment, increases expression | 1 |
| sodium arsenite | increases expression | 1 |
| cobaltous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| abrine | increases expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases reaction, increases expression | 1 |
| jinfukang | decreases expression | 1 |
| PCI 5002 | affects cotreatment, increases expression | 1 |
| Resveratrol | affects cotreatment, increases expression | 1 |
| Atrazine | decreases expression | 1 |
| Cannabidiol | increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Enzyme Inhibitors | decreases activity, increases O-linked glycosylation | 1 |
| Hydralazine | affects cotreatment, increases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Plant Extracts | affects cotreatment, increases expression | 1 |
| Selenium | decreases expression | 1 |
| Smoke | decreases expression | 1 |
| Tetrachlorodibenzodioxin | affects expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.